Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Journal of the National Cancer Institute|July 7, 2016
Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States VeteransDaphne Y Xiao, Suhong Luo, Katiuscia O'Brian, et al.
American Journal of Hematology|August 4, 2009
A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromesMike G Martin, Richard A Walgren, Elizabeth Procknow, et al.
American Journal of Hematology|April 12, 2014
A phase I dose escalation study of oral bexarotene in combination with intravenous decitabine in patients with AMLJohn S Welch, Haixia Niu, Geoffrey L Uy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) versus Filgrastim (Neupogen) in Combination with Plerixafor for Autologous Stem Cell Mobilization in Patients with Multiple Myeloma and Non-Hodgkin LymphomaPavan Kumar Bhamidipati, Mark A Fiala, Brenda J Grossman, et al.
Blood Advances|January 4, 2020
Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCTTalha Badar, Narendranath Epperla, Aniko Szabo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 10, 2015
Maintenance Therapy with Decitabine after Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic SyndromeIskra Pusic, Jaebok Choi, Mark A Fiala, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 4, 2015
Hematologic Recovery after Pretransplant Chemotherapy Does Not Influence Survival after Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia PatientsKhoan Vu, Shivaprasad Manjappa, John F DiPersio, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 24, 2011
Prognostic significance of FDG-PET in relapsed or refractory classical Hodgkin lymphoma treated with standard salvage chemotherapy and autologous stem cell transplantationJacob P Smeltzer, Amanda F Cashen, Qin Zhang, et al.
Pageof 10